NGM Biopharmaceuticals, Inc. EPS - Earnings per Share 2019-2023 | NGM
NGM Biopharmaceuticals, Inc. eps - earnings per share from 2019 to 2023. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
| NGM Biopharmaceuticals, Inc. Annual EPS |
| 2023 |
$-1.73 |
| 2022 |
$-2.03 |
| 2021 |
$-1.56 |
| 2020 |
$-1.50 |
| 2019 |
$-0.85 |
| 2018 |
$-0.08 |
| 2017 |
$-2.37 |
| NGM Biopharmaceuticals, Inc. Quarterly EPS |
| 2023-12-31 |
$-0.34 |
| 2023-09-30 |
$-0.35 |
| 2023-06-30 |
$-0.46 |
| 2023-03-31 |
$-0.58 |
| 2022-12-31 |
$-0.43 |
| 2022-09-30 |
$-0.59 |
| 2022-06-30 |
$-0.59 |
| 2022-03-31 |
$-0.42 |
| 2021-12-31 |
$-0.35 |
| 2021-09-30 |
$-0.37 |
| 2021-06-30 |
$-0.48 |
| 2021-03-31 |
$-0.36 |
| 2020-12-31 |
$-0.41 |
| 2020-09-30 |
$-0.43 |
| 2020-06-30 |
$-0.38 |
| 2020-03-31 |
$-0.28 |
| 2019-12-31 |
$0.66 |
| 2019-09-30 |
$-0.17 |
| 2019-06-30 |
$-0.13 |
| 2019-03-31 |
$-1.21 |
| 2018-12-31 |
$2.23 |
| 2018-09-30 |
$-1.15 |
| 2018-06-30 |
$-0.52 |
| 2018-03-31 |
$-0.64 |
